Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

EMBYX vs. MEDEX: which is better?

Bottom line

EMBYX vs MEDEX: the short answer

EMBYX (Emerging Markets Bond Fund) and MEDEX (MFS Emerging Markets Debt Fund) are both mutual funds.

Updated Nov 19, 2026

EMBYX vs MEDEX side by side

EMBYXMEDEX
TypeMutual fundMutual fund
Fund familyVanEckMFS
CategoryEmerging-Markets BondEmerging-Markets Bond
Expense ratio—1.32%
Annual cost per $10k—$132
10-yr cost on $10k (prospectus)—$1,601
Max front load—0%
12b-1 fee—0.5%
1-yr return—+6.6%
5-yr return (annualized)—+0.7%
10-yr return (annualized)—+2.7%
Best quarter——
Worst quarter——
Net assets (fund)—$7.5B
Number of holdings—504
Portfolio turnover—69%
Returns as of—Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

EMBYX and MEDEX share none of their top holdings.

EMBYX top 10

    MEDEX top 10

    1. MFS Institutional Money Market Portfolio — 4.42%
    2. Argentina Republic Government International Bonds — 1.35%
    3. Argentina Republic Government International Bonds — 1.08%
    4. Ecuador Government International Bonds — 0.96%
    5. Argentina Republic Government International Bonds — 0.95%
    6. Dominican Republic — 0.89%
    7. Colombia Government International Bonds — 0.82%
    8. Dominican Republic — 0.73%
    9. Paraguay Government International Bonds — 0.70%
    10. Ecuador Government International Bonds — 0.69%

    FAQ

    What is the difference between EMBYX and MEDEX?
    EMBYX (Emerging Markets Bond Fund) and MEDEX (MFS Emerging Markets Debt Fund) are both mutual funds.
    Should I own both EMBYX and MEDEX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.